Stuart C. Apfel

3.8k total citations
36 papers, 2.7k citations indexed

About

Stuart C. Apfel is a scholar working on Cellular and Molecular Neuroscience, Physiology and Neurology. According to data from OpenAlex, Stuart C. Apfel has authored 36 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cellular and Molecular Neuroscience, 15 papers in Physiology and 11 papers in Neurology. Recurrent topics in Stuart C. Apfel's work include Nerve injury and regeneration (21 papers), Pain Mechanisms and Treatments (15 papers) and Botulinum Toxin and Related Neurological Disorders (9 papers). Stuart C. Apfel is often cited by papers focused on Nerve injury and regeneration (21 papers), Pain Mechanisms and Treatments (15 papers) and Botulinum Toxin and Related Neurological Disorders (9 papers). Stuart C. Apfel collaborates with scholars based in United States and Israel. Stuart C. Apfel's co-authors include John A. Kessler, Joseph C. Arezzo, Richard B. Lipton, Bruce T. Adornato, Howard J. Federoff, Michael Brownlee, Herbert H. Schaumburg, William J. Litchy, Charles A. Sanders and Douglas E. Wright and has published in prestigious journals such as JAMA, Neurology and Annals of Neurology.

In The Last Decade

Stuart C. Apfel

36 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart C. Apfel United States 21 1.2k 1.0k 566 561 407 36 2.7k
Anna Maria Di Giulio Italy 32 1.3k 1.1× 596 0.6× 270 0.5× 282 0.5× 1.2k 3.0× 135 3.2k
Aviva J. Symes United States 32 771 0.6× 237 0.2× 456 0.8× 342 0.6× 1.3k 3.2× 70 2.7k
Angelo Schenone Italy 36 2.6k 2.1× 552 0.5× 336 0.6× 2.1k 3.8× 1.2k 2.9× 218 5.0k
Tomio Sasaki Japan 37 728 0.6× 567 0.5× 198 0.3× 1.9k 3.4× 1.1k 2.7× 155 4.4k
Steven Petratos Australia 27 949 0.8× 312 0.3× 172 0.3× 245 0.4× 891 2.2× 71 2.5k
Hiroshi Nawashiro Japan 36 695 0.6× 341 0.3× 142 0.3× 1.2k 2.2× 1.2k 2.9× 171 4.1k
Michael P. Murphy United States 24 556 0.5× 1.5k 1.4× 203 0.4× 344 0.6× 1.3k 3.2× 72 3.6k
G Harta United States 12 598 0.5× 296 0.3× 169 0.3× 302 0.5× 1.2k 3.0× 13 2.6k
Ruilan Zhang United States 28 1.1k 0.9× 500 0.5× 204 0.4× 591 1.1× 2.0k 4.9× 38 5.4k
Roberto Del Bo Italy 36 736 0.6× 513 0.5× 246 0.4× 913 1.6× 2.0k 4.9× 88 3.5k

Countries citing papers authored by Stuart C. Apfel

Since Specialization
Citations

This map shows the geographic impact of Stuart C. Apfel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart C. Apfel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart C. Apfel more than expected).

Fields of papers citing papers by Stuart C. Apfel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart C. Apfel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart C. Apfel. The network helps show where Stuart C. Apfel may publish in the future.

Co-authorship network of co-authors of Stuart C. Apfel

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart C. Apfel. A scholar is included among the top collaborators of Stuart C. Apfel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart C. Apfel. Stuart C. Apfel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simon, James A., Anita H. Clayton, Sharon J. Parish, Stuart C. Apfel, & L. Millheiser. (2019). Effects of Alcohol Administered with Flibanserin in Healthy Premenopausal Women: A Randomized, Double-Blind, Single-Dose Crossover Study. The Journal of Sexual Medicine. 17(1). 83–93. 12 indexed citations
2.
Pryma, Daniel A., Bennett B. Chin, Richard B. Noto, et al.. (2018). Efficacy and Safety of High-Specific-Activity 131I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma. Journal of Nuclear Medicine. 60(5). 623–630. 191 indexed citations
3.
Apfel, Stuart C. & John A. Kessler. (2007). Neurotrophic Factors in the Treatment of Peripheral Neuropathy. Novartis Foundation symposium. 196. 98–119. 11 indexed citations
4.
Apfel, Stuart C.. (2002). Nerve growth factor for the treatment of diabetic neuropathy: What went wrong, what went right, and what does the future hold?. International review of neurobiology. 50. 393–413. 235 indexed citations
5.
Apfel, Stuart C.. (2001). Neurotrophic Factor Therapy – Prospects and Problems. Clinical Chemistry and Laboratory Medicine (CCLM). 39(4). 351–5. 60 indexed citations
6.
Apfel, Stuart C., Bruce T. Adornato, Roy Freeman, et al.. (2000). Efficacy and Safety of Recombinant Human Nerve Growth Factor in Patients With Diabetic Polyneuropathy. JAMA. 284(17). 2215–2215. 274 indexed citations
7.
Apfel, Stuart C.. (2000). Neurotrophic Factors and Pain. Clinical Journal of Pain. 16(Supplement). S7–S11. 53 indexed citations
8.
Apfel, Stuart C.. (2000). Managing the Neurotoxicity of Paclitaxel (Taxol®) and Docetaxel (Taxotere®) with Neurotrophic Factors. Cancer Investigation. 18(6). 564–573. 21 indexed citations
9.
Apfel, Stuart C.. (1999). Neurotrophic Factors and Diabetic Peripheral Neuropathy. European Neurology. 41(Suppl. 1). 27–34. 73 indexed citations
10.
Apfel, Stuart C.. (1999). Neurotrophic factors in the therapy of diabetic neuropathy. The American Journal of Medicine. 107(2). 34–42. 87 indexed citations
11.
Apfel, Stuart C.. (1999). Nerve regeneration in diabetic neuropathy. Diabetes Obesity and Metabolism. 1(1). 3–11. 28 indexed citations
12.
Apfel, Stuart C., et al.. (1996). Nerve Growth Factor Regulates the Expression of Brain-Derived Neurotrophic Factor mRNA in the Peripheral Nervous System. Molecular and Cellular Neuroscience. 7(2). 134–142. 181 indexed citations
13.
Apfel, Stuart C., et al.. (1995). Kappa opioid receptors participate in nerve growth factor-induced hyperalgesia. Neuroscience. 68(4). 1199–1206. 15 indexed citations
14.
Apfel, Stuart C. & John A. Kessler. (1995). Neurotrophic factors in the therapy of peripheral neuropathy.. PubMed. 4(3). 593–606. 39 indexed citations
15.
Apfel, Stuart C. & John A. Kessler. (1994). Nerve growth factor in the treatment of sensory neuropathy. Drug News & Perspectives. 7(2). 69–74. 2 indexed citations
16.
Apfel, Stuart C., Joseph C. Arezzo, Michael Brownlee, Howard J. Federoff, & John A. Kessler. (1994). Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Research. 634(1). 7–12. 241 indexed citations
17.
Apfel, Stuart C., Joseph C. Arezzo, Mary S. Moran, & John A. Kessler. (1993). Effects of administration of ciliary neurotrophic factor on normal motor and sensory peripheral nerves in vivo. Brain Research. 604(1-2). 1–6. 30 indexed citations
18.
Apfel, Stuart C., Joseph C. Arezzo, Michael E. Lewis, & John A. Kessler. (1993). The Use of Insulin‐like Growth Factor I in the Prevention of Vincristine Neuropathy in Mice. Annals of the New York Academy of Sciences. 692(1). 243–245. 20 indexed citations
19.
Apfel, Stuart C., Richard B. Lipton, Joseph C. Arezzo, & John A. Kessler. (1991). Nerve growth factor prevents toxic neuropathy in mice. Annals of Neurology. 29(1). 87–90. 195 indexed citations
20.
Lipton, Richard B., Stuart C. Apfel, Janice P. Dutcher, et al.. (1989). Taxol produces a predominantly sensory neuropathy. Neurology. 39(3). 368–368. 250 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026